Neonatal anemia after in-utero exposure to natalizumab: A real-world retrospective cohort study. (PubMed, Mult Scler Relat Disord) - Sep 15, 2026 - "Natalizumab exposure during pregnancy, including third trimester, was not associated with an increased risk of clinically significant neonatal anemia in our unicentric retrospective cohort. These findings provide reassuring safety data, although larger prospective studies are required to help therapeutic management during pregnancy."
Journal • Real-world evidence • Retrospective data • Anemia • CNS Disorders • Hematological Disorders • Multiple Sclerosis
|
|
Célia Pereira Bettiol; Emmeline di Donato; Ninon Dupuis; Thomas Parsy
|